Depression and Diabetes among Low-Income Hispanics: Design Elements of a Socio-Culturally Adapted Collaborative Care Model Randomized Controlled Trial

Abstract

Objective:

This article describes design elements of the Multifaceted Depression and Diabetes Program (MDDP) randomized clinical trial. The MDDP trial hypothesizes that a socioculturally adapted collaborative care depression management intervention will reduce depressive symptoms and improve patient adherence to diabetes self-care regimens, glycemic control, and quality-of-life. In addition, baseline data of 387 low-income, 96% Hispanic, enrolled patients with major depression and diabetes are examined to identify study population characteristics consistent with trial design adaptations.

Methods:

The PHQ-9 depression scale was used to identify patients meeting criteria for major depressive disorder (1 cardinal depression symptom + a PHQ-9 score of > 10) from two community safety net clinics. Design elements included sociocultural adaptations in recruitment and efforts to reduce attrition and collaborative depression care management.

Results:

Of 1,803 diabetes patients screened, 30.2% met criteria for major depressive disorder. Of 387 patients enrolled in the clinical trial, 98% had Type 2 diabetes, and 83% had glycated hemoglobin (HbA1c) levels ≥ 7%. Study recruitment rates and baseline data analyses identified socioeconomic and clinical factors that support trial design and intervention adaptations. Depression severity was significantly associated with diabetes complications, medical comorbidity, greater anxiety, dysthymia, financial worries, social stress, and poorer quality-of-life.

Conclusion:

Low-income Hispanic patients with diabetes experience high prevalence of depressive disorder and depression severity is associated with socioeconomic stressors and clinical severity. Improving depression care management among Hispanic patients in public sector clinics should include intervention components that address self-care of diabetes and socioeconomic stressors.

Keywords

depression diabetes randomized clinical trial collaborative care low-income

Get full access to this article

View all access options for this article.

References

Centers for Disease Control and Prevention, Health disparities experienced by Hispanics: United States. MMWR 2004; 53(40): 935–937.

Umpierrez

Gonzalez

Umpierrez

Pimentel

. Diabetes mellitus in the Hispanic/Latino population: An increasing health care challenge in the United States. American Journal of Medical Science 2007; 334(4): 274–282.

Kirk

Passmore

Bell

. Disparities in A1C levels between Hispanic and non-Hispanic white adults with diabetes: A meta-analysis. Diabetes Care 2008; 31(2): 240–246.

Burke

Williams

Haffner

. Elevated incidence of type 2 diabetes in San Antonio, Texas compared to that of Mexico City, Mexico. Diabetes Care 2001; 24(9): 1573–1578.

West

Klein

Rodriguez

. Diabetes and diabetic retinopathy in a Mexican-American population: Proyecto VER. Diabetes Care 2001; 24(7): 1204–1209.

Duru

Mangione

Steers

. The association between clinical care strategies and the attenuation of racial/ethnic disparities in diabetes care: The Translating Research into Action for Diabetes (TRIAD) Study. Medical Care 2006; 44(12): 1121–1128.

Harris

. Racial and ethnic differences in health care access and heath outcomes for adults with type 2 diabetes. Diabetes Care 2001; 24(3): 454–459.

Nichols

Brown

. Unadjusted and adjusted prevalence of diagnosed depression in type 2 diabetes. Diabetes Care 2003; 26(3): 744–749.

Ford

Strine

Mokdad

. Prevalence of depression among U.S. adults with diabetes: Findings from the 2006 behavioral risk factor surveillance system. Diabetes Care 2008; 31(1): 105–107.

10.

Ali

Stone

Peters

Davies

Khunti

. The prevalence of co-morbid depression in adults with Type 2 diabetes: A systematic review and meta-analysis. Diabetes Medicine 2006; 23: 1165–1173.

11.

Pineda

OAE

Stewart

Galindo

Stephens

. Diabetes, depression, and metabolic control in Latinas. Cultural Diversity Ethnic Minority Psychology 2007; 13(3): 225–231.

12.

De Groot

Anderson

Freedland

. Association of depression and diabetes complications: A meta-analysis. Psychosomatic Medicine 2001; 63(4): 619–630.

13.

Lustman

Anderson

Freedland

. Depression and poor glycemic control: A meta-analysis review of the literature. Diabetes Care 2000; 23(7): 934–942.

14.

Egede

. Diabetes, major depression, and functional disability among U.S. adults. Diabetes Care 2004; 27(2): 421–428.

15.

Lanting

Joung

MacKenbach

Lamberts

Boostma

. Ethnic differences in mortality, end-stage complications, and quality of care among diabetic patients. Diabetes Care 2005; 28(9): 2280–2288.

16.

Clouse

Lustman

Freedland

. Depression and coronary heart disease in women with diabetes. Psychosomatic Medicine 2003; 65: 376–383.

17.

Katon

Rutter

Simon

. The association of co-morbid depression with mortality in patients with Type 2 diabetes. Diabetes Care 2005; 28(11): 2668–2672.

18.

Richardson

Egede

Mueller

. Effect of race/ethnicity and persistent recognition of depression on mortality in elderly men with Type 2 diabetes and depression. Diabetes Care 2008; 31(5): 880–881.

19.

Ciechanowski

Katon

Russo

. Depression and diabetes: Impact of depressive symptoms on adherence, function and costs. Archives of Internal Medicine 2000; 160(21): 3278–3285.

20.

Egede

Zheng

Simpson

. Co-morbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care 2002; 25(3): 464–470.

21.

Katon

Russo

Von Korff

Lin

EHB

Ludman

Ciechanowski

. Long-term effects on medical costs of improving depression outcomes in patients with depression and diabetes. Diabetes Care 2008 (online).

22.

Musselman

Betan

Larsen

Phillips

. Relationship of depression to diabetes Types 1 and 2: Epidemiology, biology, and treatment. Biological Psychiatry 2003; 54(3): 317–329.

23.

Pinto-Meza

Fernandez

Serrano-Blanco

Haro

. Adequacy of antidepressant treatment in Spanish primary care: A naturalistic six-month follow-up study. Psychiatric Services 2008; 59(1): 78–83.

24.

Egede

. Major depression in individuals with chronic medical disorders: Prevalence, correlates and association with health resource utilization, lost productivity and functional disability. General Hospital Psychiatry 2007; 29(5): 409–416.

25.

Sclar

Robison

Skaer

. Ethnicity/race and the diagnosis of depression and use of antidepressants by adults in the United States. International Clinical Psychopharmacy 2008; 23(2): 106–109.

26.

Sarkar

Piette

Gonzales

. Preferences for self-management support: Findings from a survey of diabetes patients in safety-net health systems. Patient Educational Counseling 2008; 70(1): 102–110.

27.

Gonzalez

Safren

Cagliero

. Depression, self-care, and medication adherence in type 2 diabetes: Relationships across the full range of symptom severity. Diabetes Care 2007; 30(9): 2222–2227.

28.

Goodnick

. Use of antidepressants in treatment of co-morbid diabetes mellitus and depression as well as in diabetic neuropathy. Annals of Clinical Psychiatry 2001; 13(1): 31–41.

29.

Gross

Olfson

Gameroff

. Depression and glycemic control in Hispanic primary care patients with diabetes. Journal of General Internal Medicine 2005; 20(5): 460–466.

30.

Katon

Von Korff

Lin

. The pathways study: A randomized trial of collaborative care in patients with diabetes and depression. Archives of General Psychiatry 2004; 61(10): 1042–1049.

31.

Katon

Unützer

Fan

. Cost-effectiveness and net benefit of enhanced treatment of depression for older adults with diabetes and depression. Diabetes Care 2006; 29(2): 265–270.

32.

Borowsky

Rubenstein

Meredith

. Who is at risk of nondetection of mental health problems in primary care? Journal of General Internal Medicine 2000; 15(6): 381–388.

33.

Cabassa

Hansen

Palinkas

Ell

. Azúcar y nervios: Explanatory models and treatment experiences of Hispanics with diabetes and depression. Social Science and Medicine 2008; 66(12),2413–2424.

34.

Spitzer

Kroenke

Williams

. Validation and utility of a self-report version of PRIME-MD: The PHQ primary care study. Primary care evaluation of mental disorders. Patient Health Questionnaire. Journal of the American Medical Association 1999; 282(18): 1737–1744.

35.

Huang

Chung

Kroenke

. Using the Patient Health Questionnaire-9 to measure depression among racially and ethnically diverse primary care patients. Journal of General Internal Medicine 2006; 21(6): 547–552.

36.

Kroenke

Spitzer

Williams

. The PHQ–9: Validity of a brief depression severity measure. Journal of General Internal Medicine 2001; 16(9): 606–613.

37.

Löwe

Spitzer

Gräfe

. Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians' diagnoses. Journal of Affective Disorders 2004; 78(2): 131–140.

38.

Löwe

Kroenke

Herzog

. Measuring depression outcome with a brief self-report instrument: Sensitivity to change of the Patient Health Questionnaire (PHQ-9). Journal of Affective Disorders 2004; 81(1): 61–66.

39.

Löwe

Gräfe

Zipfel

. Diagnosing ICD-10 depressive episodes: Superior criterion validity of the Patient Health Questionnaire. Psychotherapy and Psychosomatics 2005; 73(6): 386–390.

40.

Wittkampf

Naeije

Schene

. Diagnostic accuracy of the mood module of the Patient Health Questionnaire: A systematic review. General Hospital Psychiatry 2007; 29(5): 388–395.

41.

Cameron

Crawford

Lawton

. Psychometric comparison of PHQ-9 and HADS for measuring depression severity in primary care. British Journal of General Practice 2008; 58(1): 32–36.

42.

Simon

Ludman

Tutty

. Telephone psychotherapy and telephone care management for primary care patients starting antidepressant treatment: A randomized controlled trial. Journal of the American Medical Association 2004; 292(8): 935–942.

43.

World Health Organization. Alcohol Use Disorders Identification Test—“English.” Vinson

Galliher

. Comfortably engaging: Which approach to alcohol screening should we use? Annals of Family Medicine 2004; 2(5): 398–404.

44.

Derogatis

Lipman

Rickels

. The Hopkins Symptom Checklist (HSCL): A measure of primary symptom dimensions. Modern Problems in Pharmacopsychiatry 1974; 7: 79–110.

45.

Katon

Von Korff

Lin

. Collaborative management to achieve treatment guidelines: Impact of depression in primary care. Journal of the American Medical Association 1995; 273: 1026–1031.

46.

Katon

Robinson

Von Korff

. A multifaceted intervention to improve treatment of depression in primary care. Archives of General Psychiatry 1996; 53(10): 924–932.

47.

First

Spitzer

Gibbon

. Structured Clinical Interview for DSM-IV Axis 1 Disorders (SCID). Washington, DC: American Psychiatric Press Inc; 1996.

48.

Toolbert

Hampson

Russell

. The summary of diabetes self-care activities measure: Results from 7 studies and a revised scale. Diabetes Care 2000; 23(7): 943–950.

49.

Whitty

Steen

Eccles

A new self-completion outcome measure for diabetes: Is it responsive to change?

Quality Life Research 1997; 6(5): 407–413.

50.

Krein

Heisler

Piette

Makki

Kerr

. The effect of chronic pain on diabetes patients' self-management. Diabetes Care 2005; 28(1): 65–70.

51.

Derogatis

Melisaratos

. The Brief Symptom Inventory: An introductory report. Psychology and Medicine 1983; 13(3): 595–505.

52.

Cervantes

Padilla

de Snyder

Salgado N

. The Hispanic stress inventory: A culturally relevant approach to psychosocial assessment. Psychological Assessment 1991; 3(3): 438–447.

53.

Ware

Sherbourne

. The MOS-36 item short-form health survey (SF-36). Medical Care 1992; 30(6): 473–481.

54.

Sullivan

Katon

Russo

Dobie

Sakai

. A randomized trial of nortriptyline for severe chronic tinnitus: Effects on depression, disability, and tinnitus symptoms. Archives of Internal Medicine 1993; 153(19): 2251–2259.

55.

Cooper-Patrick

Powe

Jenckes

. Identification of patient attitudes and preferences regarding treatment of depression. Journal of General Internal Medicine 1997; 12(7): 431–438.

56.

Dwight-Johnson

Sherbourne

Liao

. Treatment preferences among depressed primary care patients. Journal of General Internal Medicine 2000; 15(8): 527–534.

57.

Dwight-Johnson

Ell

Jiuan-Lee

. Can collaborative care address the needs of low-income Latinas with co-morbid depression and cancer? Results from a randomized pilot study. Psychosomatics 2005; 46(3): 224–232.

58.

Nezu

Perri

. Problem-solving therapy for depression: Theory, research and clinical guidelines. New York: Wiley, 1989.

59.

Gilmer

Walker

Johnson

Philis-Tsimikas

Unützer

. Improving treatment of depression among Latinos with diabetes using Project Dulce and IMPACT. Diabetes Care 2008 (online).

60.

Ell

Xie

Quon

. Collaborative care management of depression among low-income patients with cancer: A randomized controlled trial. Journal of Clinical Oncology 2009; 26(27): 4488–4496.

61.

Bernal

Bonilla

Bellido

. Ecological validity and cultural sensitivity for outcome research: Issues for the cultural adaptation and development of psychosocial treatments with Hispanics. Journal of Abnormal Child Psychology 1995; 23(1): 67–82.

62.

Katon

Rutter

Ludman

. A randomized trial of relapse prevention of depression in primary care. Archives of General Psychiatry 2001; 58(3): 241–247.

63.

Ell

Xie

Wells

. Economic stress among low-income women with cancer: Effects on quality of life. Cancer 2008; 112(3): 616–625.

64.

Miranda

Chung

Green

. Treating depression in predominantly low-income young minority women: A randomized controlled trial. Journal of the American Medical Association 2003; 290(1): 57–65.

65.

Jarjoura

Polen

Baum

. Effectiveness of screening and treatment for depression in ambulatory indigent patients. Journal of General Internal Medicine 2004; 19(1): 78–84.

66.

Washington

Bowles

Saha

. Transforming clinical practice to eliminate racial-ethnic disparities in healthcare. Journal of General Internal Medicine 2008; 23: 685–891.

67.

Golden

Lazo

Carnethon

. Examining a bidirectional association between depressive symptoms and diabetes. Journal of the American Medical Association 2008; 299(23): 2751–2759.